Skip to main content
. 2018 Feb 20;9(5):1189–1195. doi: 10.1111/jdi.12804

Table 1.

Demographic and clinical characteristics of the study population

Variable DM + PAD (n = 440) DM (n = 442) P
Male 223 (50.7) 246 (55.7) 0.139
Age (years) 66.70 ± 7.57 60.43 ± 7.95 <0.001***
HbA1c (%) 9.4 (3.3) 8.9 (3.2) 0.024*
TC (mmol/L) 5.13 ± 0.88 4.93 ± 0.97 0.002**
TG (mmol/L) 2.55 (1.67) 2.43 (1.67) 0.119
HDL‐C (mmol/L) 1.34 ± 0.25 1.40 ± 0.28 <0.001***
LDL‐C (mmol/L) 3.29 ± 0.98 3.11 ± 0.98 0.005**
BMI (kg/m2) 25.55 ± 3.09 25.06 ± 3.17 0.020*
Smoking 200 (45.5) 159 (36) 0.004**
Hypertension 249 (56.6) 214 (48.4) 0.015*
Lipid‐lowering therapy 151 (34.3) 122 (27.6) 0.031*
Duration of diabetes (year) 13.38 ± 5.82 10.60 ± 5.43 <0.001***
Coronary heart disease 168 (38.2) 87 (19.7) <0.001***
Cerebral infarction 131 (29.8) 64 (14.5) <0.001***

Data are mean ± standard deviation, medians (interquartile range) or percentages. *P < 0.05, **P < 0.01 and ***P < 0.001. BMI, body mass index; DM, patients with type 2 diabetes mellitus; DM + PAD, peripheral artery disease patients with type 2 diabetes mellitus; HbA1c, glycated hemoglobin; HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride.